We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
External Validation Of IMP3 Expression As An Independent Prognostic Marker For Metastatic Progression And Death For Patients With Renal Carcinona
Cancer / Oncology UroToday.com - This trial was a validation of IMP3 as marker for the aggressiveness of renal cell carcinoma. It confirmed that IMP3 positivity can predict increased metastasis and decreased survival in renal cell carcinoma patients.Validation studies are not widely performed or reported on biomarkers, but provide valuable insight on the importance of these markers on a larger scale.
Custom Search
